Gilead Sciences Inc.’s (GILD) shares fell 5% after a leaked draft report indicated that its experimental antiviral drug remdesivir failed to show clinical …
Ray Dalio, a former stock broker, is the founder and CEO of Bridgewater Associates, a successful hedge fund. In fact, LCH Investments reported …
One of the more anticipated events of early 2015 played out on Friday – detailed results from an early study of Biogen Idec Inc's (NASDAQ:BIIB) experimental …
